152 related articles for article (PubMed ID: 9137991)
41. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis.
Wang HH; Lin CY; Huang TP
Nephrol Dial Transplant; 2003 Jun; 18(6):1181-9. PubMed ID: 12748353
[TBL] [Abstract][Full Text] [Related]
42. Granulocyte stimulating factor in patients on peritoneal dialysis and LPS stimulated peripheral blood mononuclear cells.
Brauner A; Hylander B; Lu Y
Inflammation; 1998 Aug; 22(4):393-401. PubMed ID: 9675610
[TBL] [Abstract][Full Text] [Related]
43. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
44. [Peritonitis caused by Nocardia farcinica in a patient undergoing continuous ambulatory peritoneal dialysis (note)].
Liassine N; Rahal K
Arch Inst Pasteur Alger; 1992; 58():95-102. PubMed ID: 1309148
[TBL] [Abstract][Full Text] [Related]
45. Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis.
Azap OK; Timurkaynak F; Sezer S; Cağir U; Yapar G; Arslan H; Ozdemir N
Transplant Proc; 2006 Mar; 38(2):411-2. PubMed ID: 16549133
[TBL] [Abstract][Full Text] [Related]
46. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
Lin CY; Huang TP
Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
[TBL] [Abstract][Full Text] [Related]
47. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Fieren MW; Van den Bemd GJ; Bonta IL
Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
[TBL] [Abstract][Full Text] [Related]
48. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
[TBL] [Abstract][Full Text] [Related]
49. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis.
Mlambo NC; Hylander B; Brauner A
Inflammation; 1999 Apr; 23(2):131-9. PubMed ID: 10213269
[TBL] [Abstract][Full Text] [Related]
50. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.
Zalewska A; Głowacka E; Wyczółkowska J; Tchórzewski H; Narbutt J; Sysa-Jedrzejowska A
Mediators Inflamm; 2006; 2006(1):81767. PubMed ID: 16864908
[TBL] [Abstract][Full Text] [Related]
51. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
[TBL] [Abstract][Full Text] [Related]
52. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement.
Jo YI; Song JO; Park JH; Lee JH; Shin SK
Nephrology (Carlton); 2007 Oct; 12(5):437-40. PubMed ID: 17803465
[TBL] [Abstract][Full Text] [Related]
53. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane.
Zemel D; ten Berge RJ; Struijk DG; Bloemena E; Koomen GC; Krediet RT
Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256
[TBL] [Abstract][Full Text] [Related]
55. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth.
Hausmann MJ; Rogachev B; Weiler M; Chaimovitz C; Douvdevani A
Kidney Int; 2000 Feb; 57(2):476-86. PubMed ID: 10652024
[TBL] [Abstract][Full Text] [Related]
56. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
[TBL] [Abstract][Full Text] [Related]
57. Phenotypic alterations of recruited eosinophils in peritoneal fluid eosinophilia.
Hellman C; Lundahl J; Hylander B; Halldén G
Perit Dial Int; 2000; 20(3):295-300. PubMed ID: 10898046
[TBL] [Abstract][Full Text] [Related]
58. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD.
Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733
[TBL] [Abstract][Full Text] [Related]
59. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis.
Schäfer K; Schumann RR; Stöteknuel S; Böhler J; Schollmeyer P; Dobos GJ
Adv Perit Dial; 1997; 13():210-3. PubMed ID: 9360683
[TBL] [Abstract][Full Text] [Related]
60. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
